New Mexico is proposing new cannabis generation standards intended to shore up provisions to its therapeutic pot program without flooding the quickly extending business sector.

The Department of Health distributed a proposition Tuesday to restrain medicinal cannabis development to 1,750 develop plants for every authorized maker.

The earlier 450-plant farthest point was struck during this time in light of a claim by the state’s biggest dealer and the mother of a youngster who is dependent on cannabis oil to treat a type of epilepsy.

Juvenile seedlings shorter than 8 inches won’t check toward the breaking point so makers can explore different avenues regarding plant strains.

A state at the forefront of the U.S. opioid and drug overdose epidemic is turning to its medical marijuana program to reduce suffering from drug use and addiction.

New Mexico health officials on Thursday expanded the list of qualifying conditions for the state's medical cannabis program to include opioid use disorder, joining several other states. Other qualifying conditions that were added include Alzheimer's disease, autism spectrum disorder and three degenerative neurological disorders.

Patient enrollment in New Mexico’s medical marijuana program grew at a fast clip in April.

The New Mexico Department of Health says patient enrollment in the cannabis program for health ailments such as cancer, chronic pain and post-traumatic stress disorder increased by 1,632 to 72,375 in April. That’s the equivalent of a 28% annual growth rate.

New Mexico’s largest medical marijuana seller said Monday that statewide growth in medical cannabis sales trailed far behind enrollment gains between March 2018 and March 2019.

Albuquerque-based Ultra Health says annual medical marijuana sales grew by 16%. That’s less than half the 39% growth rate for enrollment.

Democratic Gov. Michelle Lujan Grisham signed a pair of bills into law last week amending the state’s medical cannabis program to expand patients’ access to the plant and to provide additional legal protections.

One month after policymakers failed to pass a bill legalizing marijuana in the state, New Mexico has signed into effect a law to decriminalize cannabis. Governor Michelle Lujan Grisham authorized the legislation, which will reduce the punishment for possession of up to a half ounce of weed from up to 15 days in jail to a fee of $50.

The Senate passed SB 323 in March by a vote of 30 to 8. The House took its time deliberating over some Judiciary Committee amendments, eventually approving the legislation mere hours before its session concluded.

Yesterday Senate Bill 406 passed the Senate Floor (33-2). The measure, sponsored by Senator Gerald Ortiz y Pino (D-Bernalillo) seeks to and expand access to medical cannabis in New Mexico. Currently many medical cannabis patients still face discrimination and lack access to their medicine.

Statement from Senator Ortiz y Pino:

Often in the media, general conversations about marijuana’s medicinal benefits reduce the plant’s 100-plus cannabinoids to a focus of one — cannabidiol, or CBD, as it’s commonly referred. CBD is non-psychoactive, presenting an easier entry point for new users while THC includes the intoxicating “high” cannabis is known for. One reductive consensus you might hear is that CBD contains all the good therapeutic value of cannabis, while THC includes virtually known and only benefits those who want to get high.